A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

Exclusion Criteria

• •Experienced any SAEs (serious adverse events) that were related or possibly related to study drug during participation in Study 04-001-01
• •Early termination from study 04-001-01
• •Any new condition that could interfere with the evaluation of the subject, interpretation of safety data, or compliance with the protocol requirements
• •Experiencing AEs (adverse events) such that in the opinion of the investigator, per protocol, study drug administration or safe participation in this study would be precluded.
• •Taken any disallowed medications noted in Study 04-001-01 between the completion of Study 04-001-01 and entry into this trial